Recombinant multi-species AMPD1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine AMPD1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Adenosine monophosphate deaminase 1 catalyzes the deamination of AMP to IMP in skeletal muscle and plays an important role in the purine nucleotide cycle. Two other genes have been identified, AMPD2 and AMPD3, for the liver- and erythocyte-specific isoforms, respectively. Deficiency of the muscle-specific enzyme is apparently a common cause of exercise-induced myopathy and probably the most common cause of metabolic myopathy in the human. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene.[provided by RefSeq, Feb 2010]
The Alternative Names of target: AMPD1,AMP deaminase 1,AMP deaminase isoform M, Myoadenylate deaminase,MAD,MADA,MMDD
Go
to AMPD1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-TA002-Ab-1/ GM-Tg-hg-TA002-Ab-2 | Human AMPD1 protein | Human |
GM-Tg-rg-TA002-Ab-1/ GM-Tg-rg-TA002-Ab-2 | Rat AMPD1 protein | Rat |
GM-Tg-mg-TA002-Ab-1/ GM-Tg-mg-TA002-Ab-2 | Mouse AMPD1 protein | Mouse |
GM-Tg-cynog-TA002-Ab-1/ GM-Tg-cynog-TA002-Ab-2 | Cynomolgus/Rhesus macaque AMPD1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-TA002-Ab-1/ GM-Tg-felg-TA002-Ab-2 | Feline AMPD1 protein | Feline |
GM-Tg-cang-TA002-Ab-1/ GM-Tg-cang-TA002-Ab-2 | Canine AMPD1 protein | Canine |
GM-Tg-bovg-TA002-Ab-1/ GM-Tg-bovg-TA002-Ab-2 | Bovine AMPD1 protein | Bovine |
GM-Tg-equg-TA002-Ab-1/ GM-Tg-equg-TA002-Ab-2 | Equine AMPD1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-TA002-Ab-1/ GM-Tg-hg-TA002-Ab-2;
GM-Tg-rg-TA002-Ab-1/ GM-Tg-rg-TA002-Ab-2;
GM-Tg-mg-TA002-Ab-1/ GM-Tg-mg-TA002-Ab-2; GM-Tg-cynog-TA002-Ab-1/ GM-Tg-cynog-TA002-Ab-2; GM-Tg-felg-TA002-Ab-1/ GM-Tg-felg-TA002-Ab-2; GM-Tg-cang-TA002-Ab-1/ GM-Tg-cang-TA002-Ab-2; GM-Tg-bovg-TA002-Ab-1/ GM-Tg-bovg-TA002-Ab-2; GM-Tg-equg-TA002-Ab-1/ GM-Tg-equg-TA002-Ab-2 |
Products Name | AMPD1 protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | AMPD1 |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine AMPD1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.